These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 18566582

  • 1. Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia.
    Horacek JM, Tichy M, Jebavy L, Pudil R, Ulrychova M, Maly J.
    Exp Oncol; 2008 Jun; 30(2):157-9. PubMed ID: 18566582
    [Abstract] [Full Text] [Related]

  • 2. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
    Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J.
    Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
    [Abstract] [Full Text] [Related]

  • 3. The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia.
    Horacek JM, Vasatova M, Tichy M, Pudil R, Jebavy L, Maly J.
    Exp Oncol; 2010 Jul; 32(2):97-9. PubMed ID: 20693970
    [Abstract] [Full Text] [Related]

  • 4. Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation.
    Horacek JM, Tichy M, Pudil R, Jebavy L, Zak P, Ulrychova M, Slovacek L, Maly J.
    Neoplasma; 2008 Jul; 55(6):532-7. PubMed ID: 18999883
    [Abstract] [Full Text] [Related]

  • 5. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
    Peivandi AA, Dahm M, Opfermann UT, Peetz D, Doerr F, Loos A, Oelert H.
    Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
    [Abstract] [Full Text] [Related]

  • 6. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
    Horacek JM, Pudil R, Tichy M, Jebavy L, Zak P, Slovacek L, Maly J.
    Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
    [Abstract] [Full Text] [Related]

  • 7. Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia.
    Horacek JM, Jebavy L, Vasatova M, Pudil R, Tichy M, Jakl M, Maly J.
    Bratisl Lek Listy; 2013 Sep; 114(12):708-10. PubMed ID: 24329509
    [Abstract] [Full Text] [Related]

  • 8. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł, Kasprzak JD, Peruga J, Lipiec P, Drozdz J, Krzemińska-Pakuła M, Smigielski J.
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [Abstract] [Full Text] [Related]

  • 9. Assessment of anthracycline-induced cardiotoxicity with electrocardiography.
    Horacek JM, Jakl M, Horackova J, Pudil R, Jebavy L, Maly J.
    Exp Oncol; 2009 Jun; 31(2):115-7. PubMed ID: 19550402
    [Abstract] [Full Text] [Related]

  • 10. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
    Horácek JM, Pudil R, Tichý M, Jebavý L, Strasová A, Praus R, Zák P, Malý J.
    Neoplasma; 2005 Jun; 52(5):430-4. PubMed ID: 16151589
    [Abstract] [Full Text] [Related]

  • 11. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria.
    Collinson PO, Gaze DC, Morris F, Morris B, Price A, Goodacre S.
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):273-80. PubMed ID: 16824277
    [Abstract] [Full Text] [Related]

  • 12. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.
    McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.
    Eur Heart J; 2008 Dec; 29(23):2843-50. PubMed ID: 18682444
    [Abstract] [Full Text] [Related]

  • 13. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.
    Mavinkurve-Groothuis AM, Kapusta L, Nir A, Groot-Loonen J.
    Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478
    [Abstract] [Full Text] [Related]

  • 14. Temporal pattern of cardiac troponin I after thoracotomy and lung surgery.
    Vikenes K, Andersen KS, Farstad M, Nordrehaug JE.
    Int J Cardiol; 2004 Sep; 96(3):403-7. PubMed ID: 15301894
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a proposed panel of cardiac markers for the diagnosis of acute myocardial infarction in patients with atraumatic chest pain.
    Chang CC, Ip MP, Hsu RM, Vrobel T.
    Arch Pathol Lab Med; 1998 Apr; 122(4):320-4. PubMed ID: 9648898
    [Abstract] [Full Text] [Related]

  • 16. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting.
    Saadeddin SM, Habbab MA, Sobki SH, Ferns GA.
    Med Sci Monit; 2000 Apr; 6(4):708-12. PubMed ID: 11208396
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of cardiac troponin I and other marker proteins in patients with chronic renal failure.
    Nakai K, Nakai K, Nagane Y, Obara W, Sato M, Ohi K, Matsumoto N, Takanashi N, Itoh C.
    Clin Exp Nephrol; 2004 Mar; 8(1):43-7. PubMed ID: 15067515
    [Abstract] [Full Text] [Related]

  • 18. Progress in myocardial damage detection: new biochemical markers for clinicians.
    Mair J.
    Crit Rev Clin Lab Sci; 1997 Mar; 34(1):1-66. PubMed ID: 9055056
    [Abstract] [Full Text] [Related]

  • 19. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK, Malik V, Yadav R, Seth S, Ramakrishnan L, Kalaivani M, Reddy SM, Subramaniam GK, Govindappa R, Kakani M.
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [Abstract] [Full Text] [Related]

  • 20. [Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology].
    Vasatová M, Tichý M, Horácek JM, Pudil R, Horáková L, Palicka V.
    Cas Lek Cesk; 2009 May; 148(12):591-6. PubMed ID: 20662394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.